← Evidence map

ArticleFrontiers in oncology2026

Case Report: Short-term disease control with subsequent icotinib therapy in EGFR L858R/C797S, T790M-negative lung adenocarcinoma after osimertinib resistance.

Shihang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Case Report: Short-term disease control with subsequent icotinib therapy in EGFR L858R/C797S, T790M-negative lung adenocarcinoma after osimertinib resistance. | OpenQuestion